Find and Pitch Jounalists, Get Your Story Covered

Tags: biotech leadership pharma Research & Development research-development

	Profile	Recent Articles on Subject
1	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The kids are alright: How pharma can make inroads with Gen Z - 10 days ago Oncology, obesity and more: Where pharma R&D is headed in 2025 - 2 months ago From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - 3 months ago 2024 PharmaVoice 100s: Tech and AI Wizards - 4 months ago As election day nears, Trump and Harris veer in different directions on pharma - 4 months ago M&A is ready to explode, and that’s good news for pharma layoffs - 6 months ago Read to lead: 6 books pharma execs swear by - 7 months ago Pharma CFOs need R&D vigilance in tough economic times - about 1 year ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	As financial headwinds pick up, pharmas are aiming to squeeze more ROI from their R&D - 17 days ago Pharma’s forecast for 2025: Sowing seeds of a rebound - 22 days ago Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - about 1 month ago The ability to pivot will be ‘key’ as pharma’s tariff threat looms - about 1 month ago PharmaVoice’s Crystal Ball: The industry’s AI future - about 2 months ago 3 closely watched drugs that failed in the clinic - 2 months ago Pharma takes aim at a wily foe — the Epstein-Barr virus - 4 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - 4 months ago 2024 PharmaVoice 100s: Trailblazers - 4 months ago 2024 PharmaVoice 100s: Standout Leaders - 4 months ago What 3 layoff stories reveal about pharma’s troubles - 6 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 6 months ago Is anyone taking the world’s priciest drugs? - 6 months ago What pharma has learned from AI - 7 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 9 months ago Where competition is heating up in pharma - 9 months ago The biggest questions hanging over pharma in 2024 - about 1 year ago Pharma execs sound off on trends and policies they’re tracking in 2024 - about 1 year ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - about 1 year ago 3 standout digital innovations in pharma this year - about 1 year ago PharmaVoice 100s: Entrepreneurs - over 1 year ago PharmaVoice 100s: Clinical trial gurus - over 1 year ago 5 minutes with — IDEA Pharma’s Mike Rea - over 1 year ago
3	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Biopharma in 2025: Outlook for Obesity Meds, Drug Prices, Regulation & More - about 2 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - 3 months ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - 4 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 5 months ago STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more - 11 months ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - 11 months ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - about 1 year ago STAT+: Pharmalittle: White House takes aim at pharma patents to lower drug prices; Sanofi CEO defends reducing earnings forecast - about 1 year ago STAT+: Pharmalittle: Pfizer is leaving the BIO trade group; CVS drug-pricing plan may not lower costs for consumers - about 1 year ago STAT+: Pharmalittle: Sanofi plans to spin off its consumer health biz; EMA says no evidence GLP-1 drugs linked to thyroid cancer - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago
5	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 5 months ago
6	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Is pharma still fearful of the Inflation Reduction Act? - 6 months ago
7	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	June 2024 Products Column - 8 months ago
8	Mike Hennessy Jr, President and CEO Pharmacy Times Pro middleweight boxer. UK/Ireland. BoxingSports	Pharmacists Are Vital to Heart Health - about 1 year ago
9	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	Pharma has a misinformation problem — and execs could be on the hook - about 1 year ago Pharma takes a gut check of microbiome drugs - about 1 year ago What are pharma’s next blockbusters? - about 1 year ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - about 1 year ago Humans can’t shake the mosquito threat. Here’s what pharma has in the pipeline. - over 1 year ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - over 1 year ago Has the science of anti-aging caught up with the dream of a longer life? - over 1 year ago
10	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	2024 - about 1 year ago

Journalists covering pharma